Comparing two transitioning strategies to paliperidone palmitate once-every-6-months
Adults with schizophrenia who transitioned to PP6M from either PP1M or PP3M experienced similarly low relapse rates. Additionally, symptom and functionality scores supported the primary analysis and, along with TEAE incidences, were comparable between transition groups.
Authors
- Christoph Ulrich Correll (ORCID: https://orcid.org/0000-0002-7254-5646)
- Karen L. Johnston (ORCID: https://orcid.org/0000-0002-6960-9602)
- Ibrahim Turkoz (ORCID: https://orcid.org/0000-0003-1891-2297)
- Martha Sajatovic
- R. Karl Knight
- Monica Doring
- Michael Kutch
Institutions
- Johnson & Johnson (United States) (US)
- University Hospitals of Cleveland (US)
- Donald & Barbara Zucker School of Medicine at Hofstra/Northwell (US)
- Janssen (United States) (US)
- University School (US)
- Zucker Hillside Hospital (US)
- Janssen Scientific Affairs (United States)
- Case Western Reserve University (US)
- Charité - Universitätsmedizin Berlin (DE)
- Cytel (United States) (US)
Publication Details
- Journal
- CNS Spectrums
- Published
- 2024-11-08
- DOI
- https://doi.org/10.1017/s1092852924000476
- Citations
- 2
- Primary Topic
- Cardiovascular Syncope and Autonomic Disorders
- Type
- article
- Field-Weighted Citation Impact
- 1.15